Related Experiment Video

Updated: May 12, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Pharmaceutical approval update

Marvin M Goldenberg

    P & T : a Peer-Reviewed Journal for Formulary Management
    |April 20, 2013
    PubMed

    Insights

    Cabozantinib, ponatinib, and raxibacumab are new treatments for specific cancers and anthrax. These targeted therapies offer new options for patients with these serious conditions.

    Area of Science:

    • Oncology
    • Pharmacology
    • Infectious Disease

    Background:

    • Metastatic medullary thyroid cancer, leukemia, and inhalational anthrax are serious conditions with limited treatment options.
    • Targeted therapies and novel drug development are crucial for improving patient outcomes.

    Purpose of the Study:

    • To review the efficacy and application of cabozantinib (Cometriq) for metastatic medullary thyroid cancer.
    • To evaluate ponatinib (Iclusig) in the treatment of specific leukemia types.
    • To assess the role of raxibacumab in managing inhalational anthrax.

    Main Methods:

    • Literature review of clinical trials and relevant studies.
    • Analysis of drug approval data and therapeutic guidelines.
    • Pharmacological and clinical data synthesis for each agent.

    Main Results:

    • Cabozantinib demonstrates efficacy in metastatic medullary thyroid cancer.
    • Ponatinib shows activity against certain forms of leukemia.
    • Raxibacumab is indicated for inhalational anthrax.

    Conclusions:

    • Cabozantinib, ponatinib, and raxibacumab represent significant advancements in treating these diseases.
    • These targeted therapies underscore the progress in personalized medicine and novel drug development.
    • Further research may explore expanded indications and optimal use of these agents.

    More Related Videos

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis10:33

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

    Published on: December 17, 2021

    Related Concept Videos

    FDA Approved Drugs: Changes to Approved Drugs01:26

    FDA Approved Drugs: Changes to Approved Drugs

    Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
    Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

    Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

    PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
    Drug Administration and Therapy Phases: Overview01:26

    Drug Administration and Therapy Phases: Overview

    Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
    The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
    The pharmacokinetic phase...
    Drug Regulation01:25

    Drug Regulation

    Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
    Drug Products: Biologics, Biosimilars and Interchangeables01:28

    Drug Products: Biologics, Biosimilars and Interchangeables

    Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...